Journal: J Psychosom Res. 2006 Jun;60(6):559-566.
Authors: Siegel SD, Antoni MH, Fletcher MA, Maher K, Segota MC, Klimas N.
Affiliation: Behavioral Medicine Research Center, Department of Psychology, University of Miami, Miami, FL, USA.
NLM Citation: PMID: 16731230
METHODS: Forty-one female CFS patients were classified into having either low or normal NKCA levels. These subgroups were then compared on objective measures of cognitive functioning and subjective assessments of fatigue, vigor, cognitive impairment, and daytime dysfunction.
RESULTS: Relative to CFS patients in the normal-NKCA subgroup, low-NKCA patients reported less vigor, more daytime dysfunction, and more cognitive impairment. In addition, low-NKCA patients performed less on objective measures of cognitive functioning relative to normal-NKCA patients.
CONCLUSIONS: The results are offered as preliminary evidence in support of using NKCA as an immunological subgroup marker in CFS. Findings are also discussed in terms of known associations between dysregulated immune functions, somatic symptoms, and psychological stress.
Copyright © 2005 Co-Cure
Last Revision: June 7, 2006
Please report any problems with this page to the Webmaster.